Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Determining acceptable risks: experimental and epidemiological issues

R D Kimbrough1

  • 1Institute for Evaluating Health Risks, Washington, DC 20005-3521.

Clinical Chemistry
|July 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inter-relation between environmental monitoring data, human exposure and health effects.

Environmental monitoring and assessment·2013
Same author

Polychlorinated biphenyls, dibenzo-p-dioxins, and dibenzofurans and birth weight and immune and thyroid function in children.

Regulatory toxicology and pharmacology : RTP·2001
Same author

Analysis of research studying the effects of polychlorinated biphenyls and related chemicals on neurobehavioral development in children.

Veterinary and human toxicology·2001
Same author

Mortality in male and female capacitor workers exposed to polychlorinated biphenyls.

Journal of occupational and environmental medicine·1999
Same author

Selected other effects and TEFs.

Teratogenesis, carcinogenesis, and mutagenesis·1997
Same author

Polychlorinated biphenyls (PCBs) and human health: an update.

Critical reviews in toxicology·1995
Same journal

Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

Clinical chemistry·2026
Same journal

Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

Clinical chemistry·2026
Same journal

TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

Clinical chemistry·2026
Same journal

Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

Clinical chemistry·2026
Same journal

Editor's Note: Circulating Proteolytic Products of Carboxypeptidase N for Early Detection of Breast Cancer.

Clinical chemistry·2026
Same journal

In Reply to Reflexing NT-proBNP for sFlt-1/PlGF Ratios That Fall into the Measurement Uncertainty for Preeclampsia Risk Classification.

Clinical chemistry·2026
See all related articles

Translating animal toxicology findings to human risk assessment is complex. Differences in metabolism and species-specific responses necessitate more human toxicokinetic data for accurate predictions.

Area of Science:

  • Toxicology
  • Risk Assessment
  • Biomarker Research

Background:

  • Experimental toxicology studies inform human risk assessment, but direct extrapolation is challenging.
  • High-dose chemical administration in animals can cause non-specific metabolic and nutritional effects.
  • Metabolic pathways and rates can differ significantly between high and low doses, and across species.

Purpose of the Study:

  • To highlight the limitations of current animal models in predicting human chemical risks.
  • To emphasize the need for enhanced understanding of chemical toxicokinetics in humans.
  • To address the challenges in utilizing biomarkers for predicting future health outcomes.

Main Methods:

  • Review of existing toxicological study methodologies and their limitations.

Related Experiment Videos

  • Analysis of metabolic pathway differences across species and dose levels.
  • Discussion of the requirements for human toxicokinetic data.

    • Main Results:

    • Significant variations exist in the applicability of animal toxicology results to human risk assessment.
    • Species-specific metabolic differences and dose-dependent effects complicate direct translation.
    • Current understanding of biomarker utility for disease prediction is limited by insufficient baseline and lifestyle data.

    Conclusions:

    • Accurate human risk assessment requires more detailed toxicokinetic data in humans.
    • The predictive value of biomarkers for future disease requires further investigation.
    • Establishing reliable biomarkers necessitates understanding their relationship to exposure, disease, and lifestyle factors.